Skip to main content

and
  1. Article

    Open Access

    An overview on the treatments and prevention against COVID-19

    The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to plague the world. While COVID-19 is asymptomatic in most individuals, it can caus...

    Yunes Panahi, Armita Mahdavi Gorabi, Sona Talaei, Fatemeh Beiraghdar in Virology Journal (2023)

  2. No Access

    Chapter

    COVID-19 Is an Endothelial Disease: Implications of Nitric Oxide

    Endothelial cells are a clinically important infection site for COVID-19, both as a mechanism for disease pathogenesis and as a therapeutic target. People with dysfunctional endothelium, defined by nitric oxid...

    Jason Kidde, Armita Mahdavi Gorabi in Clinical, Biological and Molecular Aspects… (2021)

  3. Article

    Open Access

    Interleukin 4 gene polymorphism (−589C/T) and the risk of asthma: a meta-analysis and met-regression based on 55 studies

    Numerous investigations have previously evaluated the association of interleukin (IL) 4 gene polymorphisms and the risk of asthma, conferring inconsistent results. To resolve the incongruent outcomes yielded from...

    Ahmad Kousha, Armita Mahdavi Gorabi, Mehdi Forouzesh, Mojgan Hosseini in BMC Immunology (2020)

  4. No Access

    Article

    The Therapeutic Potential of Mesenchymal Stem Cell–Derived Exosomes in Treatment of Neurodegenerative Diseases

    Neurologic complications are commonly regarded as irreversible impairments that stem from limited potential of regeneration of the central nervous system (CNS). On the other side, the regenerative potential of...

    Armita Mahdavi Gorabi, Nasim Kiaie, George E. Barreto in Molecular Neurobiology (2019)